ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

For Cause Renal Biopsies Are Heterogeneous Irrespective of Clinical Presentation

A. Cherukuri, S. Balasubramanian, P. Prasad, C. Angel, A. Lewington, C. Newstead, B. Clark, R. Baker

St.James's University Hospital, Leeds, United Kingdom

Meeting: 2013 American Transplant Congress

Abstract number: 38

Deteriorating renal function either evidenced by a rise in serum creatinine or proteinuria remains the most important indication for a late transplant biopsy. Over the last 4 years we have performed 148 “for cause” biopsies at our centre. In this study we analyse the histology of the biopsies in relation to the presenting indication. We have also collected serum samples for the detection of Donor Specific Antibody (DSA). The allografts were classified into those with acute dysfunction (AD, n=15), creeping creatinine (CC, n=29), isolated proteinuria (P, n=46) and proteinuria with creeping creatinine (P+CC, n=58). Creeping creatinine was defined as a slope >0.35 and P<0.05 on the regression analysis of 1/creatinine values over 2 years prior to the biopsy. Patients with≥3 urine protein estimates of>0.5g/day had significant proteinuria. We have found that the histology was quite heterogeneous with no relation to the indication.

Presentation% Recurrent GN% Microcirculation damage% T cell Rejection% IFTA% Others%
AD 7 (N=1) 20 (N=3) 13 (N=2) 47 (N=7) 13 (N=2)
CC 10 (N=3) 38 (N=11) 7 (N=2) 38 (N=11) 7 (N=2)
P 15 (N=7) 39 (N=18) 14 (N=6) 28 (N=13) 14 (N=6)
P-CC 14 (N=8) 36 (N=21) 5 (N=3) 33 (N=19) 5 (N=3)

In 116 patients with IFTA/microcirculation damage (MCI=g/cg/ptc≥1)/late T cell rejection BANFF scores were largely similar.

In 53 patients with MCI, c4d deposition in the peritubular capillaries remained the single most important predictor for outcomes over a 2year follow-up period. There was a trend towards worse survival in patients with higher degree of scarring with clinical presentation not having any impact on the outcome.

In summary, we propose that the histology of late “for cause” biopsies is heterogeneous irrespective of the indication and key histological features rather than clinical presentation affects the short term outcomes.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Cherukuri A, Balasubramanian S, Prasad P, Angel C, Lewington A, Newstead C, Clark B, Baker R. For Cause Renal Biopsies Are Heterogeneous Irrespective of Clinical Presentation [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/for-cause-renal-biopsies-are-heterogeneous-irrespective-of-clinical-presentation/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences